These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28294596)

  • 21. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
    Silva MT; Portaels F; Pedrosa J
    Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A diverted total synthesis of mycolactone analogues: an insight into Buruli ulcer toxins.
    Chany AC; Casarotto V; Schmitt M; Tarnus C; Guenin-Macé L; Demangel C; Mirguet O; Eustache J; Blanchard N
    Chemistry; 2011 Dec; 17(51):14413-9. PubMed ID: 22127975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.
    Niang F; Sarfo FS; Frimpong M; Guenin-Macé L; Wansbrough-Jones M; Stinear T; Phillips RO; Demangel C
    Sci Rep; 2015 Dec; 5():17693. PubMed ID: 26634444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions.
    Ogbechi J; Ruf MT; Hall BS; Bodman-Smith K; Vogel M; Wu HL; Stainer A; Esmon CT; Ahnström J; Pluschke G; Simmonds RE
    PLoS Pathog; 2015 Jul; 11(7):e1005011. PubMed ID: 26181660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring.
    Sarfo FS; Le Chevalier F; Aka N; Phillips RO; Amoako Y; Boneca IG; Lenormand P; Dosso M; Wansbrough-Jones M; Veyron-Churlet R; Guenin-Macé L; Demangel C
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1237. PubMed ID: 21811642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation.
    Guenin-Macé L; Veyron-Churlet R; Thoulouze MI; Romet-Lemonne G; Hong H; Leadlay PF; Danckaert A; Ruf MT; Mostowy S; Zurzolo C; Bousso P; Chrétien F; Carlier MF; Demangel C
    J Clin Invest; 2013 Apr; 123(4):1501-12. PubMed ID: 23549080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.
    Warryn L; Dangy JP; Gersbach P; Gehringer M; Schäfer A; Ruf MT; Ruggli N; Altmann KH; Pluschke G
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008357. PubMed ID: 32589646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic insights into the inhibition of Sec61-dependent co- and post-translational translocation by mycolactone.
    McKenna M; Simmonds RE; High S
    J Cell Sci; 2016 Apr; 129(7):1404-15. PubMed ID: 26869228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.
    Gama JB; Ohlmeier S; Martins TG; Fraga AG; Sampaio-Marques B; Carvalho MA; Proença F; Silva MT; Pedrosa J; Ludovico P
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3066. PubMed ID: 25101965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naturally occurring a loss of a giant plasmid from Mycobacterium ulcerans subsp. shinshuense makes it non-pathogenic.
    Nakanaga K; Ogura Y; Toyoda A; Yoshida M; Fukano H; Fujiwara N; Miyamoto Y; Nakata N; Kazumi Y; Maeda S; Ooka T; Goto M; Tanigawa K; Mitarai S; Suzuki K; Ishii N; Ato M; Hayashi T; Hoshino Y
    Sci Rep; 2018 May; 8(1):8218. PubMed ID: 29844323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buruli ulcer (Mycobacterium ulcerans infection).
    Walsh DS; Portaels F; Meyers WM
    Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].
    En J; Ishii N; Goto M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):5-10. PubMed ID: 21404590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.
    Bieri R; Bolz M; Ruf MT; Pluschke G
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004450. PubMed ID: 26863011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of
    Foulon M; Pouchin A; Manry J; Khater F; Robbe-Saule M; Durand A; Esnault L; Delneste Y; Jeannin P; Saint-André JP; Croué A; Altare F; Abel L; Alcaïs A; Marion E
    Sci Adv; 2020 Feb; 6(9):eaax7781. PubMed ID: 32133396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional adaptation of
    Robbe-Saule M; Foulon M; Poncin I; Esnault L; Varet H; Legendre R; Besnard A; Grzegorzewicz AE; Jackson M; Canaan S; Marsollier L; Marion E
    Virulence; 2021 Dec; 12(1):1438-1451. PubMed ID: 34107844
    [No Abstract]   [Full Text] [Related]  

  • 36. The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER.
    Hall BS; Hill K; McKenna M; Ogbechi J; High S; Willis AE; Simmonds RE
    PLoS Pathog; 2014 Apr; 10(4):e1004061. PubMed ID: 24699819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons: Mechanisms underlying hypoalgesia in Buruli ulcer.
    Anand U; Sinisi M; Fox M; MacQuillan A; Quick T; Korchev Y; Bountra C; McCarthy T; Anand P
    Mol Pain; 2016; 12():. PubMed ID: 27325560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Mycobacterium ulcerans toxin, mycolactone, induces apoptosis in primary human keratinocytes and in HaCaT cells.
    Bozzo C; Tiberio R; Graziola F; Pertusi G; Valente G; Colombo E; Small PL; Leigheb G
    Microbes Infect; 2010 Dec; 12(14-15):1258-63. PubMed ID: 20800104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells.
    George KM; Pascopella L; Welty DM; Small PL
    Infect Immun; 2000 Feb; 68(2):877-83. PubMed ID: 10639458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.
    Mve-Obiang A; Lee RE; Umstot ES; Trott KA; Grammer TC; Parker JM; Ranger BS; Grainger R; Mahrous EA; Small PL
    Infect Immun; 2005 Jun; 73(6):3307-12. PubMed ID: 15908356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.